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Abstract 
Shape memory polymers (SMPs) have been found to be promising biomaterials for a variety of 
medical applications; however, the clinical translation of such technology is dependent on 
tailorable properties such as gravimetric changes in degradation environments. For SMPs 
synthesized from amino-alcohols, oxidation resulting in rapid mass loss may be problematic in 
terms of loss of material functionality as well as toxicity and cytocompatibility concerns. Control 
of gravimetric changes was achieved through the incorporation of small molecule antioxidants, 
either directly into the polymer matrix or included in microparticles to form a SMP composite 
material. Direct incorporation of small molecule antioxidants, such as phenolic alcohols, was 
found to alter shape memory attributes and increase elastic modulus at the expense of the strain to 
failure. Such changes could not ensure retention of the antioxidants and therefore did not increase 
oxidative stability. However, the inclusion of antioxidants in microparticles was found to produce 
materials with similar thermomechanical and shape memory properties while increasing oxidative 
resistance compared to controls. The microparticle composite SMPs also act as a platform for 
environmental sensing, such as pH-dependent fluorescence shifts and payload release, as 
demonstrated by fluorescent dyes and the release of antioxidants. The use of polyurethane-urea 
microparticles in porous SMPs is demonstrated to increase biostability of the materials, by 
approximately 25%, and ultimately extend their lifespan for use in aneurysm occlusion as 
determined through calculated in vivo degradation rates corresponding to a porcine aneurysm 
environment. 
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Introduction 
 
The degradation of polyurethanes used in medical applications has been known for 
decades, with the original formulations undergoing hydrolysis of ester bonds in chain extending 
soft segments, and subsequent formulations suffering from either hydrolysis or oxidation of 
alternative linkages, such as carbonates or ethers, respectively.1-2 The carbamate linkage may 
eventually undergo hydrolysis, resulting in amine formation that is considered a carcinogen risk 
in the case of aromatic amines, although the actual risk from this is still not certain and the 
polyurethane species are widely utilized.3-5 Degradation in polyurethane medical devices is still of 
great concern, either for medical functionality or to reduce regulatory risk associated with 
degradable materials and possible toxicity.1-2  
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One example, specific to porous polyurethane materials, is the polyurethane foam breast 
implants in which toxicity concerns have been associated with foam erosion in implantable 
biomaterials that was linked to toluene diamine.3-5 Sokolowski et al. developed a porous shape 
memory polyurethane (SMP) for cerebrovascular aneurysm occlusion based on the Mitsubishi 
thermoplastic SMP formulations.6-7 Wilson et al. developed an alternative SMP system that 
utilized aliphatic diisocyanates and multifunctional amino-alcohols as crosslinkers to produce a 
thermoset polymer with crosslinks possessing molecular weighs below 700 Da.8 These thermosets 
were intended to possess high shape memory strain recovery and minimal stress recovery, to 
leverage these materials for cardiovascular applications where wall stresses could compromise 
material functionality.8 Previous work on these materials demonstrated biocompatibility and 
functionality in aneurysm occlusion; however, degradation studies found rapid gravimetric 
changes as a result of amine oxidation, with end products including aldehydes, lower amines, and 
oxalic acid, which can lead to renal failure at sufficient concentrations.9-11 While degradable 
materials are suitable for many applications, the rapid release of degradation products presents 
significant risks for cerebrovascular aneurysms application, which may cause health concerns from 
a regulatory perspective, due to the proximity of the material to the brain.12 Tuning the rate of mass 
loss through control of biostability is an important method of reducing regulatory risk, and 
incorporation of antioxidants has previously been used to extend biostability in polymeric medical 
devices.1,13  
A goal of this work was to minimize matrix changes to retain biocompatibility of the SMP 
by forming SMP composites by incorporating polymeric particles with antioxidants.  Compositing 
offers the opportunity to incorporate multiple functionalities simultaneously, such as mechanical 
and visualization. Previous work with metal and metal oxide composite SMPs resulted in enhanced 
imaging visibility in select cases, in addition to thermo-mechanical property changes, based upon 
loading thresholds migration as a function of additive concentration, which also altered SMP foam 
stability during synthesis by compromising pore integrity.14-16 The use of polymeric particles was 
hypothesized to reduce property migration while allowing for incorporating antioxidants to control 
degradation or release as drug analogs.  
Particle systems have been proposed and tested for a variety of fields. In medical 
applications, microparticles have been proposed for drug releasing systems, chemical sensors, and 
visualization.17-21 A series of antioxidant microparticles, synthesized from a hydrolytically 
degradable vanillyl alcohol-containing copolyoxalate, was synthesized and tested in conjunction 
with dexamethasone.22-23 However, these particles would release ca 80% of the drug payload 
within 12 hours, and had sizes ranging from ca 10-15 µm.24 While the authors did not examine the 
degradation products, this polymer will also degrade into the potentially toxic oxalic acid.25 The 
same particles were previously studied for their interaction with hydrogen peroxide (H2O2) as 
radical scavengers.25 Polyketal microparticles were tested for radical scavenging by delivering 
superoxide dismutase to a model of lung fibrosis, with the ketals displaying no inflammation 
response compared with the inflammation found using the standard poly(lactic-co-glycolic acid) 
(PLGA) particles, and ultimately inhibiting lung fibrosis.25 Formation of porous polyurethane 
microspheres through solution templating, using calcium carbonate solution, has been attempted, 
resulting in particles with ca 7.5 µm diameters.26-28 A solution of dimethyl sulfoxide (DMSO) and 
water (H2O) was used to produce porous polyurethane microparticles in a one-pot reaction that 
included the use of polyvinyl alcohol and isophorone diisocyanate.29 Castor oil and methylene-di-
phenyl diisocyanate were reacted to form thermoplastic polyurethane microparticles, with water 
added to produce the polyurea.30 Acetone/water mixtures have been used with a variety of amines 
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to produce polyurea microspheres and particles with a range of sizes. A modification of this 
method, to yield poly(urethane urea) shell particles, was selected in this study due to the 
similarities with matrix composition as well as the well understood degradation products from 
particle degradation.11,31 
Numerous antioxidant systems have been studied in polymer systems, including hindered 
amine light scavengers (HALS), phenol and phenol-derivatives, and phosphites in polyurethane 
systems across numerous applications, including biomedical materials, although rarely for 
specifically increasing biostability as determined through gravimetric analysis.32-34 Butylated 
hydroxytoluene (BHT) has been used successfully in polyethylene and its derivatives, with specific 
applications in medicine and medical materials such as improving oxidative damage that occurs 
during sterilization of total joint replacement polymeric implants.34 These antioxidants may 
scavenge the radicals that preferentially attack the tertiary amines, thus reducing mass loss of the 
SMP.  However, direct utilization of in-chain antioxidants or antioxidant degradation products 
requires the initial polymer chain degradation that may compromise the bulk integrity of the 
polymer. This can be avoided by incorporating antioxidants into the abovementioned SMP 
composites.   
 Here we present a method for producing hollow poly(urethane urea) microparticles with 
average diameters ranging from 2 to 10 µm. Particles were synthesized with or loaded with 
antioxidants prior to incorporation into SMPs. Characterization of these materials indicates that 
this method for including antioxidants is superior to the direct incorporation of small molecule 
antioxidants, as the composites do not display significant thermo-mechanical property changes or 
shape recovery kinetic differences. Additionally, the SMP composites were also demonstrated as 
a platform for continuous release and degradation environment detection as proof of concept for 
expanded material functionalities. 
 
Methods and Materials 
Materials: Materials were purchased from Sigma-Aldrich and used without modification 
unless otherwise stated.  Hexamethylene diisocyanate (98%, HDI), isophorone diisocyanate (98%, 
IPDI), triethanolamine (99%, TEA), N,N,N’,N’ tetrakis (hydroxypropyl) ethylenediamine (98%, 
HPED), diethanolamine (99%, DEA), butylated hydroxytoluene (BHT), 1,2,2,6,6 tetramethyl 
piperidinol (piper), and 2,2’-methylenebis(6-tert-butyl-methylphenol (methyl) (SI Figure 1), 
Phloxine B (PhB) and Nile blue chloride (Nile) were used as monomers. Ethanol (97%, EtOH) 
and isopropyl alcohol (99.5%) were used as solvents for cleaning the materials after synthesis and 
degradation testing, respectively. Cobalt chloride (CoCl2) and hydrogen peroxide (H2O2, 50%) 
were used for degradation analysis. Ethyl isocyanate (98%) was used for model reactions. 
Acetonitrile (99.93%, HPLC grade), methanol (50% in H20 with 0.1% v/v formic acid, LCMS 
grade), methanol (99.9%, LCMS grade), and water solution (0.5 % v/v formic acid, HPLC grade) 
were used with liquid chromatography. 
General: Fourier transform infrared spectroscopy (FTIR) attenuated total reflectance (ATR) was 
performed using a Bruker ALPHA infrared spectrometer (Bruker, Billerica, MA); 48 scans per 
spectra for both background and samples were used. Spectra data were collected in absorption 
mode with a resolution of 4 cm-1. OPUS™ software was used to examine spectra, identify peaks, 
and perform baseline and atmospheric corrections. Spectral data collection was performed in 
triplicate to confirm results. X-ray photoelectron spectroscopy (XPS) (Omicron™ XPS with Argus 
detector) using a Mg/Al x-ray source was used to characterize particles and SMPs.  
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Gas chromatography mass spectrometry (GCMS, positive mode) was used to determine 
the extracted concentration using a Thermo Scientific™ DSQ II Series Single Quadrupole GCMS 
(ThermoFisher Scientific, Waltham, MA), as well as the degradation products from the model 
compounds. A 10 uL sample volume was injected, with a dwell time of 4 seconds. The initial 
temperature was 50°C, heated to 320°C at a rate of 20°C/min. The flow rate was 50 mL/min with 
a surge pressure of 0.44 psi using methanol.  
Product determination was confirmed using liquid chromatography mass spectrometry 
(LCMS). Samples were diluted 100-fold in a 50% methanol (49.95% water, 0.05% formic acid) 
solution, and injected into a normal phase C18 silica column. The injection volume was 10µL, and 
the mass flow rate was varied from 0% acetonitrile to 95% acetonitrile over a 6-minute gradient. 
An Exactive Plus OrbiTrap Mass Spectrometer (ThermoFisher Scientific, Waltham, MA) was used 
to perform MS. The capillary temperature was 100 °C. Spectral data were collected over a 30-
second integration and Xactive™ software (ThermoFisher Scientific, Waltham, MA) was used for 
analysis. 
Microparticle Synthesis: Microparticle synthesis was achieved using a modified procedure 
previously reported by Kong et al.31 In short, IPDI (5 g, 22.5 mmol) was added to a water/acetone 
solution (95 g) and mixed for 1 hour at room temperature. Reaction temperature and solvent ratio 
were varied to optimize synthetic outcomes. TEA (29.97 mmol), DEA, or HPED were dissolved, 
while stirring at 30 rpm, in the mixture. 5 g IPDI (22.5 mmol) was added over 10 minutes at a 
constant rate. The reaction was allowed to proceed overnight, yielding a viscous white solution. 
The solution was centrifuged for 5 min at 4000 rpm, and the particles were rinsed in H2O-acetone 
(30/70 ratio) three times before drying at 70°C overnight. Particles were dried and characterized 
(yield 54%).  
Microparticle Extraction and Loading: The thermoplastic core was extracted using IPA/acetone 
mixtures at 50°C for 12 hours with a one-hour sonication (solution was changed every 4 hours).31 
Particles were then centrifuged and separated from the effluent, and removal of the core was 
confirmed using differential scanning calorimetry and x-ray diffraction experiments. Loading of 
the particles was performed by dissolving 20g of antioxidant or fluorescent dye into solution and 
adding 20 g of particles. The mixture was stirred and heated to 50°C overnight. Particle solutions 
were then centrifuged, separated, washed three times using H2O/acetone, and dried overnight at 
50°C, to produce loaded microparticles (i.e. BHT-L). Synthesis of antioxidant-containing particles 
was repeated with 50% wt of antioxidants added immediately after the alcohol, prior to the 
additional IPDI. Particles were collected and washed the same way as described previously. 
Particles synthesized in this way are labeled Synth (i.e. BHT-S). A general schematic for synthesis 
is presented in Figure 1.  
Shape Memory Polymer Synthesis: Porous SMP scaffolds were synthesized using a traditional 
two-step polyurethane foam synthesis process.35 An isocyanate (NCO) premix was first made by 
adding 40% of the desired alcohols (molar % of total alcohols used; the exact percentage could be 
varied to control premix viscosity and thus scaffold pore size) to the entire amount of diisocyanate, 
with a ratio of NCO:OH of ca 2:1.35 This premix was cured at 50°C for 36 hours. The alcohol 
(OH) premix was then synthesized, consisting of the remaining alcohols, antioxidants or particles 
(5 and 10% wt), surfactants, catalysts, water, and a physical blowing agent.35 The OH premix was 
combined with the isocyanate premix along with microparticles, using a high-speed shear mixer, 
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followed by the addition of a physical blowing agent. The scaffold was cured at 90°C for 20 
minutes, followed by cold curing overnight at ambient conditions.  
Light Microscopy, Confocal Microscopy, and Scanning Electron Microscopy (SEM): SMP 
samples were cut to less than 1 mm thickness for microscopy. Using previously described methods, 
particles were characterized using light microscopy.35 SMP samples were imaged using an 
Olympus™ Fluoview 1000 laser scanning confocal microscope (LSCM) (Olympus America Inc, 
Center Valley, PA), and were excited at 543 nm utilizing less than 1% maximum intensity.14 Foam 
cell structure was determined by cutting axial and transverse samples that were examined using 
SEM. Samples were mounted on a stage and sputter coated with gold using a Cressington Sputter 
Coater (Ted Pella, Inc., Redding, CA) for 60 seconds at 20 mA. Samples were then examined 
using a Joel NeoScope JCM-5000 SEM (Nikon Instruments Inc., Melville, NY). 
Thermal Analysis: Differential scanning calorimetry (DSC) was also used to measure both wet and 
dry Tg using a Q-200 DSC (TA Instruments, Inc., New Castle, DE). Samples of ca (5.0 ± 1.0) mg 
were sealed in TZero™ aluminum pans and placed in the heating cell. Dry samples were cooled 
to equilibration at -40 °C, heated to 120 °C at 10 °C/min, cooled at 10 °C/min to -40 °C and heated 
to 120 °C at 10 °C/min. The half-height transition of the final heating cycle was the reported Tg. 
Wet samples were weighed and sealed in the same manner, and were then heated from -40°C to 
80°C at 10°C/min.  
Thermogravimetric analysis (TGA) was used to assess any changes in thermal degradation 
temperatures. A TA Q50 TGA (TA Instruments, New Castle, DE) was used to heat samples to 
500°C at 10°C/min under a mixed atmosphere of oxygen and nitrogen (60mL/min to 40 mL/min 
respectively). Samples were examined for the onset of degradation temperature and major 
transitions in the mass loss profiles 
Shape Memory Characterization: Shape recovery of cylindrical foam samples (6 mm diameter, 10 
mm length, six samples per series) crimped over a wire was examined at 50 °C in reverse osmosis 
(RO) water to determine the volume recovery behavior (strain recovery).14 Samples were crimped 
to a minimal diameter (ca 1.0 mm) using a SC150-42 Stent Crimper (Machine Solutions, Flagstaff, 
AZ). For radial compression, samples were equilibrated at 100 °C for ten minutes and then radially 
compressed and cooled to room temperature. Samples relaxed for 12 hours and were tested over 
the course of 30 minutes. ImageJ™ was used for analysis of the change in diameters over time. 
Mechanical Testing: Uniaxial tensile testing was performed on ASTM d638 IV samples using an 
Instron Tensile Tester with 500 N load cell. The extension rate was set to 5 mm/min at room 
temperature. Seven samples were tested for each species. Elastic modulus, strain to failure, and 
ultimate tensile strength were calculated. 
Fluorescence: Fluorescence wavelengths were examined using a Fluoromax Fluorometer (Horiba 
UK Limited, Middlesex, UK). Selected excitation wavelengths were determined from the literature 
and confirmed by excitation scans; PhB was excited with approximately 515 nm; Nile was excited 
at 635 nm. 
Payload Release: Release of antioxidants was studied using 2.0 g SMPs in 50 mL of IPA at 37 °C. 
Samples were withdrawn and the solution was examined using GCMS. The solution was injected 
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into the column (C18 silica, normal phase) and heated at 20 °C/min to 300 °C. UV-vis was used 
to confirm release rates. 
Degradation Analysis: Previously, the rate of degradation for control compositions was 
determined for porcine aneurysm conditions and related to the rate of degradation as demonstrated 
using accelerated oxidative solution (20% H2O2 with 0.1M CoCl2 at 37 °C).
11 A uniformly applied 
acceleration factor of 57.14 was found to model the real time degradation of the controls. Pore size 
and interconnectivity, and strut thickness were assumed to be identical and therefore were 
neglected. 
Results and Discussions 
Microparticle Synthesis 
Synthetic conditions were varied by changing solvent ratio, temperature, and alcohol 
species in solution with IPDI. The size of the particles obtained with the three amino alcohols 
(HPED, TEA, DEA) was characterized using SEM (SI Figure 2-11), with quantified metrics 
shown in Table 1.  TEA was selected for further examination due to particle size and distribution, 
as well as the suspected less hydrophilic network and more rapid release/degradation rates 
previously demonstrated in non-composite porous SMPs.11 While the smallest size distribution 
was achieved with HPED (Dw/Dn = 1.10), TEA at room temperature resulted in the smallest 
particle diameter, similar to those results reported by Kong and others using similar methods.31,36 
Results obtained by changing the temperature indicated that room temperature gave the smallest 
particle diameter of 2.43 ± 0.91 µm, a size that falls within the desired range for embolic 
applications and for particles that can be phagocytized by cells.37-38 
Poly(urethane) urea (PU) microparticles contain a thermoplastic polyurea core with the 
poly(urethane urea) crosslinked shell surrounding it. Removal of the core was achieved through 
sonication in solvent and confirmed using DSC and XRD (Figure 2), with the thermoplastic 
polyurea core displaying semi-crystalline behavior as determined by a peak at 33.843° by XRD 
(lattice spacing of 5.47 Å by Bragg equation) and a melting peak at ca 170°C, both of which are 
not present in the crosslinked shell after extraction. After core removal, the particles were loaded 
with the antioxidants or the fluorescent molecules. Loading during synthesis was viable only for 
BHT and Piper, as Methyl is not soluble in the polymer solution sufficiently. Loading percentages 
of up to 45% were attempted during synthesis and did not appear to alter particle composition or 
morphology, but the removal of BHT was a possibility during particle cleaning and so was not 
further examined. Loadings of ca 45% (wt) were achieved using physical means after synthesis.  
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Figure 1. A general overview of synthetic process, illustrating the microparticle synthesis in 
acetone/water, extraction of the particle core with the addition of antioxidants, and the synthesis 
of SMP foam using a two-step foaming method including the microparticles, which can be 
substituted for small molecule antioxidants. 
 
Figure 2. Scanning electron microscopy and XRD comparison of the areas of the original 
microspheres (PU with core) and those that have undergone extraction reveals a relative 
crystallinity of 3.3% for the starting material, which can be attributed to the thermoplastic 
polyurea core. 
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Table 1. Impact of synthetic methods on average particle diameter and distribution. 
% acetone % water Temperature 
(°C) 
Monomer Number ave 
Distribution 
Diameter 
(Dn) (µm) 
Weight ave 
Distribution 
Diameter 
(Dw) (µm) 
Dw/Dn 
70 30 50˚ TEA 6.79 10.69 1.57 
70 30 50˚ DEA 7.25 8.74 1.29 
70 30 50˚ HPED 9.54 10.48 1.10 
70 30 0 ˚C TEA 6.66 9.12 1.37 
70 30 20 ˚C TEA 2.80 4.18 1.49 
70 30 80 ˚C TEA 6.42 9.12 1.42 
30 70 20˚ TEA 6.66 9.72 1.46 
50 50 20˚ TEA 4.53 7.05 1.56 
60 40 20˚ TEA 4.69 8.29 1.77 
 
Composite SMPs Synthesis 
The spectra of the SMP foams (Figure 3) displayed the characteristic polyurethane bands 
including hydroxyl bands at 3250-3500 cm-1, the methyl band at 2800-3000 cm-1, the carbonyl 
peak at 1688 cm-1 that denotes the urethane bond and the corresponding shoulder for the urea bond 
at ca 1640 cm-1, and the skeletal carbon peak at 1252 cm-1.39 The lower wavenumbers for the 
urethane peak are due to the increased hydrogen bonding achieved using aliphatic monomers as 
well as the high urea content in the composition (due to water added during the foam blowing 
synthesis).11 The Methyl and Thio SMPs display shoulders on the carbonyl at ca 1710-1730 cm-1 
that correspond to the ester bonds in the antioxidants (Thio) or the formation of a new urethane 
linkage (Methyl) (SI Figure 12). The increase in the relative height of the urethane carbonyl of 
the Piper SMP, compared with the control, indicates the formation of the urethane linkage. 1H, 13C 
NMR confirmed the formation of urethane linkages for Methyl and Piper antioxidants; other 
examined species contained original structures and small concentrations of urea linkages. Mass 
spectroscopy (SI Figure 12) supported these findings, indicating that Methyl could form mono- 
and biurethane linkages, while Piper formed only a single urethane; BHT, Thio, and Triphen would 
only interact non-covalently.  
XPS confirmed the incorporation of greater amounts of free hydroxyls (286.4 eV) 
associated with the leftover end groups from the synthesis, as well as a shoulder peak at 288.7 eV 
associated with carbonyls.28 No differences were found for antioxidants during loading, during 
synthesis, or post-synthesis (SI Figure 13).11 The residual presence of tin, a foaming catalyst, and 
silicone, from the surfactants used, were found in all SMPs. The dual binding peak seen for the 
C1s scan at 286.6 eV may also indicate a greater presence of C-N bonds as well as hydroxyls, as 
a result of greater incorporation of the alcohol into the SMP compared to the microparticle, which 
possesses a thermoplastic core and linear shell components (urea contributions). This is supported 
by the relative area of the N1s peak displayed for the SMP compared with the particles in the 
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survey scan. Additionally, the shoulder peak in the C1s scan centered at 286.06 eV indicates a 
greater concentration of free alcohols, which is expected stoichiometrically from the preferential 
consumption of the isocyanates to form the urea, followed by urethane, then branching reactions 
due to synthetic conditions (SI Figure 13-15). The consistent shoulder at ca 288.5 eV, indicative 
of the carbonyls, is expected based on the urethane-urea nature of the materials. The qualitative 
decrease in peak strength for the SMPs may be due to the decrease in relative concentration of the 
urea/urethane carbonyl relative to the backbone.  
For the particles themselves, the Cl2s and Br3p peaks associated with PhB were found as 
fairly weak signals, indicating that the dye was not just on the surface of the particles but contained 
within the shell as well. The decreased O1s peak for the particles may be attributed to residual urea 
in the polymer shell compared to a urethane linkage, which may also explain the shoulders found 
in the C1s scans as explained above.  The dye particles did not display any changes in the N1s 
peak, which was anticipated. The antioxidant-containing particles displayed the same shoulder at 
286.6 eV as that of the other particles, but is again not found in the SMP composites, providing 
further support for this being a urea carbonyl peak. Most importantly for these particles, the O1s 
peak (531.7 eV) was found to be broader for the particles where antioxidants were loaded in after 
synthesis, compared to particles where the antioxidants were included during synthesis. For 
example, the Piper synth peak is sharp and centered at ca 531 eV, whereas Piper load is broader 
with a distinctive shoulder closer to ca 532.5 eV, a trend which is repeated in the BHT particles. 
 
Figure 3. Spectroscopic characterization of poly(urethane urea) microparticles and SMP foams. 
XPS comparison of survey scan (A) and C1s scan (B) demonstrates the greater incorporation of 
amines from amino alcohols (C1s peak at ~286 eV) and the presence of silicone from surfactants 
(survey scan below 200 eV). Fluorescence profiles, displaying minimal wavelength shift, that 
A
D 
B
D 
C
D 
D
D 
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corresponds more closely to uncrosslinked phloxine, compared with previous studies utilizing 
crosslinked phloxine in SMP foams (C), and the shift in the carbonyl peak indicative of linkages 
other than the carbamate/urea peaks due to small molecules added to the SMP (D). 
Fluorescence spectroscopy of SMP composites with PhB-containing particles was compared with 
SMPs doped with PhB and PhB in solution; emission spectra display a red-shift as a result of 
crosslinking and formation of a urethane linkage for PhB. The emission spectra peak for PhB in 
solution (1 mM in H2O) was found to be 573 nm, 580 nm for the SMP composite, and 589 nm for 
the crosslinked PhB. This indicates that the PhB, enclosed in the microparticles, retains the 
functionality of the fluorescent molecule and that the payload is in fact incorporated in the particle 
rather than on the surface, thus providing further support for the XPS analysis results. 
 
Figure 4. SMP foam with TEA- microparticles (control) (A), BHT-microparticles (B). The 
agglomeration of microparticles can be seen to occur along the edges of pore membranes (C, D). 
Aggregate diameters (E) and pore sizes (F) determined using microscopy. 
 
The average strut diameter, determined from SEM, was ca 20.7 ± 3.6 µm. The average 
aggregate diameter was 13.4 ± 10.1 µm, as displayed in Figure 4. It was determined through 
optical microscopy of fluorescent PhB particles, but aggregates were visible during SEM analysis 
as well; aggregate diameter seemed to be independent of composition. Qualitatively, pore 
membranes were found to be primarily intact with only pinholes between pores, with triangular 
struts throughout. Pore sizes were found to be consistent with the composite SMPs, with no 
statistical variation between species of the antioxidant or fluorescent molecule; qualitative 
evaluation of antioxidants, directly incorporated into the SMP foams, indicated a variation in foam 
cell formation resulting in widely variable pores, membranes, and bulk foam morphology. 
Antioxidant or dye species did not seem to impact pore morphology when included in 
microparticles (SI Figure 16-17). 
Thermomechanical Characterization  
A B C 
D E F
D 
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Tensile testing comparisons revealed minimal differences between the microparticle-
containing SMPs. However, SMPs with antioxidants directly incorporated into them were found 
to have widely varied mechanical behaviors (Table 2, Figure 5). For small molecule antioxidant 
additives, an initial analysis was performed using HDI-based foams (SI Table 1) before being 
repeated using TMHDI-based materials, with trends reproducible for both formulations. Methyl 
again displayed enhanced properties relative to the control and the other examined species. The 
elastic modulus of the control was 1.45 MPa, while that of Methyl was 2.32 MPa; strain to failure 
for the control was 45.2% while Methyl’s was 32.2%. Of the other examined small molecule 
antioxidants, all species displayed increased strain to failure and tensile strength, except for 
Triphen. The Triphen SMP displayed nearly twice the strain to failure (71.0%), while also 
possessing reduced tensile strength (1.41 MPa compared to 1.64MPa for the control) and a lower 
elastic modulus (0.44 MPa). Microparticles do not change the mechanical properties significantly 
when compared with the control (no particles/additives) composition. The changes that are 
displayed are not statistically significant and may be attributable to the intrinsic variability in SMP 
foam morphology that is obtained through the foaming process.  
Table 2. Mechanical properties of control SMPs and those containing small molecule 
antioxidants only as well as microparticles loaded with antioxidants (n=7). 
Species Elastic Modulus 
(MPa) 
Strain to Failure 
(%) 
Control SMP 1.45 ± 0.19 45.2 ± 11.6 
SMP Composite with Piper 
microparticles 
1.32 ± 0.26 52.9 ± 8.2 
SMP with Piper small molecule additive 1.41 ± 0.19 56.6 ± 5.2 
SMP Composite with Methyl 
microparticles 
1.19 ± 0.18 61.2 ± 26.1 
SMP with Methyl small molecule 
additive  
2.32 ± 0.44 32.2 ± 7.3 
SMP Composite with BHT 
microparticles 
1.52 ± 0.29 51.2 ± 5.8 
SMP with BHT small molecule additive  1.40 ± 0.32 51.0 ± 6.2 
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Figure 5. Shape memory behavior (both volumetric and strain recoveries) of porous SMPs with 
antioxidant small molecules (10%, A) and microparticles (10%, B) over 15 minutes in 37°C RO 
H2O; mechanical behavior (tensile) of SMPs with antioxidant small molecules (10%, C) and 
microparticles (10%, D).  
 
 
Table 3. Thermal characterizations of antioxidant SMPs (n=3). 
Species Tg (°C) Wet Tg (°C) Td (onset temp) (°C) Td (derivative peak) (°C) Tm (°C) (Monomer melt 
transition, °C) 
Control 55.3 ± 0.3 10.4 ± 1.0 239 ± 2 273 ± 3 - 
SMP Composite 
with Piper 
microparticles 
55.5 ± 0.4 10.2 ± .08 251 ± 1 278 ± 2 - (130) 
SMP with Piper 
small molecule 
additive 
55.0 ± 0.3 11.5 ± 1.1 250 ± 1 279 ± 1 - (130) 
SMP Composite 
with Methyl 
microparticles 
55.6 ± 0.2 10.4 ± 1.1 258 ± 1 300 ± 2 - (125) 
A 
C 
B 
D 
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SMP with Methyl 
small molecule 
additive 
61.5 ± 0.2 14.2 ± 1.4 260 ± 3 299 ± 4 - (125) 
SMP Composite 
with BHT 
microparticles 
55.3 ± 1.0 10.5 ± 0.7 261 ± 3 301 ± 2 - (71) 
SMP with BHT 
small molecule 
additive 
57.2 ± 0.8 10.2 ± 1.9 261 ± 1 303 ± 2 - (70) 
SMP with Thio 
small molecule 
additive 
41.0 ± 3.0 5.2 ± 0.5 236 ± 1 267 ± 1 39.5 ± 1.1 (40) 
SMP with 
Triphen small 
molecule additive 
38.9 ± 0.3 12.3 ± 1.3 247 ± 3 279 ± 4 - (22) 
 
For the small molecule antioxidant SMPs, the Methyl SMP displayed increased Tg from 
55.3 °C (control) to 61.5 °C, which is attributed to the aromatic groups in the SMP backbone. 
Interestingly, Piper did not display an increase, but this may be due to the antioxidant being a 
pendant group rather than a crosslinker, with the increase in chain ends counterbalanced by the 
increase in backbone chain rigidity due to the pendant groups. The physical addition of the BHT 
(Tg = 57.2 °C) did not statistically alter the Tg. Thio and Triphen seemed to act as plasticizers 
causing the drop in the Tg of the SMP, with 41.0 °C and 38.9 °C, respectively. A melt 
transformation was found for Thio at approximately 40 °C (SI Figure 18), which corresponds to 
the melting point of the monomer. The other SMPs did not display melting points, despite all 
monomers displaying melting points within the examined range (BHT Tm ca 70 °C, Piper Tm ca 
130 °C, Methyl Tm ca 125 °C, and Triphen Tm ca 22°C). 
The use of the microparticles with antioxidants did not alter the Tg. Control microparticles 
were found to not have a significant Tg, an expected result due to the high concentration of urea 
linkages; microparticle behavior is discussed further by Kong et al.31 Dry Tg of the microparticle 
SMP composites was found to be ca 65°C, regardless of additive species. Wet Tg was ca 28°C. 
The microparticles themselves had Tg of ca 90 °C and 150 °C, consistent with results reported by 
Kong for similar materials.31 However, unlike Kong’s results, no peak at 200 °C was seen, which 
was expected for our system.31 Additionally, extraction of the particle core and addition of the 
TEA removed the Tg at 150 °C and added a Tg at ca 43 °C consistent with the thermal behavior 
for a similar polyurethane system.11 
Thermal degradation of the control composite SMP composition displayed an onset 
degradation of ca 240 °C (derivative local maxima of ca 275 °C), indicative of polyurethane 
thermolysis. Methyl and BHT antioxidants resulted in increased derivative peaks of thermal 
degradation temperatures (control at ca 273°C, BHT at 303°C, and Methyl at 299°C). All 
antioxidant SMPs, except for the Thio, displayed an increased onset of thermal degradation, a trend 
which was repeated with the antioxidant-containing microparticles. This trend was reproduced for 
  14 
bare particles. Literature values for polyurethane thermal degradation display similar thermal 
degradation values in the range of 230-250 °C for aliphatic polymers; full thermal degradation 
curves are displayed in SI Figure 18.11,40-41  
Shape Memory Characterization 
All composite SMPs examined have similar shape recovery profiles compared to the 
control SMP, unlike the SMPs containing small molecule antioxidants. This desired outcome was 
achieved for the first time, by incorporating functional polymer microparticles; previous attempts 
have failed to deliver with regards to shape memory, with metal or metal oxide-based particles, 
including tungsten, zirconium oxide, barium sulfate, and iron oxide, altering the recoverable 
strains and strain recovery rates.14-16,35,42 With small molecule antioxidants, Methyl SMPs 
displayed little shape recovery (ca 35% recoverable strain) (Figure 5) and Piper had slightly 
reduced shape memory (ca 90% recoverable strain). The Methyl-loaded particles and the Piper-
loaded particles have superior shape recovery behavior compared with the small molecules. Piper-
loaded composite SMPs, the slowest recovering composition, are capable of 100% strain recovery 
over 15 minutes (with full recovery occurring at ca 10 minutes) with similar recovery kinetics to 
the control material. By comparison, Piper, added as a small molecule, results in only ca 80% 
recovered strain by 10 minutes and a final recoverable strain of ca 90%. The other SMP species 
did not have significantly altered shape memory properties. For the Methyl SMPs, the more rigid 
aromatic backbone having formed urethane linkages and thereby increasing backbone rigidity is 
the most plausible cause for reduced strain recovery. For Piper SMPs, the decrease in crosslink 
density due to increased chain ends (as a result of adding the antioxidant) will reduce the 
recoverable strain.8  
As demonstrated through the fluorometry examination of PhB-containing particles (Figure 
3), there are some reactions between isocyanates and surface groups of the microparticles, which 
in the case of PhB, result in urethane formation; in the case of metal and metal oxide additives, 
which were not characterized for surface chemistry, the incorporation of the particles into the 
polymer matrix during foam blowing may change the crosslinking density locally, but microscopic 
analysis did reveal pore instability and collapsed sections of the SMP foam when using such 
additives.14 These sections of increased density may dramatically have altered the shape recovery 
kinetics simply due to fracture of the more dense sections.15,35 Regardless, with the presented 
polyurethane microparticles, superior incorporation without pore collapse  and additional 
crosslinking at the particle surface is achieved and does not impact the strain recovery. 
Payload Delivery and Stimuli Response 
Small molecule containing SMPs were found to release nearly all of the antioxidants in the 
matrix during cleaning, as determined by GCMS, and were therefore not examined for release 
studies. Nile blue chloride and PhB, in addition to BHT, Methyl, and Piper composite SMPs were 
examined for release of their respective molecule in vitro (Figure 6). The initial release of 
additives from the composite SMP was measured using GCMS (SI Table 2, SI Figure 19) and 
UV-vis. At 1 hr, which would be the equivalent of cleaning the SMP prior to device packaging 
and sterilization, the BHT particles appeared to have released the majority of the releasable 
payload. BHT-synth released more than 80% of the available antioxidant and BHT-load had 
released ca 50%. These 1 hr results are similar to those reported by Yoo et al. using Sudan Blue 
in a poly(urea urethane) system.43 By 1 wk, 91% of the available BHT had been released from the 
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BHT-synth and ca 75% from BHT-load. In an effort to improve loading and to examine the 
combination of small molecules and compositing, BHT and BHT (containing both microparticles 
and small molecule antioxidants) SMPs were examined and were found to release nearly 50% of 
the available antioxidant by 1 wk. It is important to note that the solution concentration of the BHT 
and BHT SMPs was approximately twice of BHT-Load or BHT-Synth, demonstrating the potential 
of these methods for applications other than the biostability tuning of the SMP. By 1 wk, the release 
from the SMPs appeared to have stabilized for simple diffusion driven release, further indicating 
the possibility of retaining some gravimetric resilience even after diffusion has occurred.  
 The Piper and Methyl SMPs retained greater than 90% of the payload by 3 weeks, as did 
the particles containing PhB and Nile fluorescent dyes. Particles in solution displayed a similar, if 
the more rapid trend, compared with the composite SMPs, demonstrating the potential of the SMPs 
as a matrix material for sustained release. Tuning the hydrophobicity and size of the added 
molecule would obviously factor into the release profiles, and further work is needed to 
characterize interaction of the matrix and particle wall in terms of release (such as methods 
presented by Yoo et al.); for long term sustained release or for oxidation-responsive conditions, 
the presented system seems to show promise.43-45  
The incorporation of fluorescent dye also presented an opportunity to incorporate an 
environmental detection functionality. Nile chloride emits a wide range of wavelengths depending 
on solvent and pH, and PhB is visible through blood as a way of monitoring the device’s location.14 
SMP composites with PhB, Nile blue, or both were examined in 1M solutions with KOH, HNO3, 
RO H2O, and H2O2. Responsiveness for Nile particles and foam was found with the acidic solution, 
with a strong emission peak displayed at 538 nm that is not present in basic or neutral solution, or 
in the presence of the peroxide. For the Nile composite SMP in a colorimetric assay, a shift in 
color was first noticed at a pH of 4 with a subtle color shift, with a more distinct change having 
occurred at pH 3. Fluorescence emission sweeps were used to determine the shift in emission 
peaks, from a sharper peak 576 nm and a broader peak at 471 nm for basic pH (pH= 12), to two 
more narrow peaks centered at 626 nm and 548 nm. With an optical tissue window in this region, 
it is hypothesized that it would be possible to remotely monitor the environmental conditions at 
the SMP-tissue interface through fluorescence microscopy.14 
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Figure 6. GCMS profiles displaying extraction of small molecule antioxidants (A) and 
release of payloads from microparticle composites at 37°C in H2O (B), confirming that while the 
BHT antioxidants were primarily removed using solvent washes, sufficient retention of active 
molecules is achieved through the use of microparticle composite SMPs. Responsiveness of 
composite SMPs loaded with Nile blue (D), and PhB with Nile blue (E) (C) as determined through 
fluorescence emissions in 1 M solutions. The colorimetric response of SMPs is displayed with a 
visual change according to pH for dual loaded composite SMP (C). 
 
Gravimetric Analysis  
Gravimetric analysis was performed with the intent of determining SMP rate of 
degradation using conditions determined for the control materials in a porcine vascular aneurysm, 
with experimental testing using accelerated conditions used to determine real time equivalency.11 
The selected antioxidants had a varied performance with regards to enhancing SMP biostability 
when incorporated as small molecules into the polymer matrix. When directly incorporated into 
the SMP as small molecules, the BHT was not retained in the SMP matrix, as confirmed through 
release studies, and the Methyl formed urethane linkages that could no longer act as radical 
scavengers. Triphen was also found to be removed during cleaning; Thio did not seem to be 
removed through diffusion but also did not improve oxidative biostability. BHT, Methyl, Triphen, 
and Thio SMPs all displayed degradation rates that match the control of SMPs. Piper was the only 
small molecule antioxidant that retained mass during the testing, with no gravimetric change 
recorded over the initial three days. After this initiation period, the degradation seemed to follow 
A B 
C 
D
 
E
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the behavior of the control materials, indicating that the Piper is preferentially oxidized and once 
consumed, oxidation begins on the amino-alcohol units of the SMP.  Interestingly, when the 
diisocyanate species was altered to the methylated TMHDI, BHT directly incorporated during 
synthesis resulted in statistically increased mass retention, on the same order as Piper in the HDI 
series; Piper was not as effective in the TMHDI SMPs (SI Figure 20) compared to BHT. 
However, while microparticles enhance the utility of same antioxidants, for the Piper series 
it was found to be no more effective than the addition of small molecules into the bulk. This is 
attributed to the maximum loading efficiency of 50% particle mass, as well as the cleaning that is 
necessary for SMPs prior to any medical application. 10% loading of particles in SMP composites 
would provide ca 0.85 g of antioxidant. Gravimetric testing revealed, as hypothesized, that the 
majority of the small molecule antioxidants diffused out of the matrix during cleaning, leaving on 
the matrix materials behind, which underwent oxidatively-induced mass loss at the same rate as 
the control SMPs. Piper antioxidants delayed the onset of mass loss, as more of the active 
antioxidant was retained compared to the other formulations. After this initiation period (3 days in 
20% H2O2 with 0.1M CoCl2), the rate of mass loss was found to approximately match that of the 
other formulations for the initial 50% mass. At this point, the rate of mass loss was reduced to ca 
60% and extended the material life from 15 days to 25 days. The use of microparticles did allow 
for better retention of BHT and Methyl antioxidant species, thereby enhancing SMP biostability 
to approximately the same degree as the Piper SMPs.  
Gravimetric results were supported by SEM imaging (Figure 8), where foam membranes 
were found to be relatively intact post-synthesis and after cleaning. Studies of solvent diffusion 
into porous polyurethanes have indicated that the outer pores will degrade primarily, as will the 
pore membranes, based upon the Fickian-derived diffusion model of moisture into polyurethane 
foams.46 Poly(ether urethane) foam membranes, materials which are also oxidation susceptible, 
will form holes or begin to erode at existing pinholes and open the cell pore, and the foam struts 
will undergo pitting and surface erosion followed by the eventual collapse of the bulk matrix.47-48 
This reported behavior is similar to the presented SMPs, where the membranes erode away rapidly 
over the course of hours for the control SMPs, with complete membrane etching by 72 hrs and 
material collapse by 7 days; this behavior is also representative of in vivo oxidation of similar 
materials.11 While these SMPs were not specifically imaged for surface blistering and strut 
cracking, these factors may also contribute to the material collapse; a lack of such features may be 
due to the rapid oxidatively induced surface erosion of the material.49 
By contrast, the antioxidant SMPs displayed increased resistant to physical changes. 
Membranes were found to remain intact over the initial 72 hours, followed by the same etching 
process as the control. In the first 72 hours, polymer etching is still occurring but is 
counterbalanced by the diffusion of antioxidants from the SMP matrix, as well as the release of 
antioxidants from the etching process. The antioxidants will scavenge the peroxy radicals at the 
SMP-solution interface and reduce oxidation of the amino-alcohols, and ultimately this reduces 
the polymer chain scission initially. After consumption of the antioxidants, SMP degradation 
occurs in the same manner as the controls and will eventually result in the collapse of the foam 
structure. Qualitatively, membrane porosity increased moderately, while the strut diameter 
decrease was faster than that for the control compared to the antioxidant SMPs, with composite 
SMPs displaying the greatest oxidation resistance overall compared to the antioxidant small 
molecules. This may factor into control of the gravimetric changes, as the gradual erosion of pores 
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and struts places microparticles in direct contact with the solution, allowing for more rapid 
antioxidant diffusion. 
Real Time Oxidative Biostability Calculations 
Based upon previously obtained in vivo data, the rate of oxidatively-induced mass loss for 
the control composition is known, as are the degradation products of the SMPs.11 The amino 
alcohols are known to oxidize to N-oxides, followed by lower amines and corresponding 
aldehydes, which may further oxidize to carboxylic acids or are part of the tissue integration 
process, depending on location and foreign body response.11 The use of TEA is designed to 
increase long-term cytocompatibility of the particles and particle degradation products, as TEA 
will not form oxalic acid as a potential by-product, unlike HPED.11 In this same study, the real 
time rate of degradation in a porcine aneurysm was determined to be most accurately modeled by 
2% H2O2, with the lifespan of the control materials found to be ca 800 days.
11 The rate of control 
SMP mass loss was scaled using the accelerated experimental tests presented in the previous 
section, and approximations of real time oxidative mass loss were calculated.11 For Methyl SMP 
composites, the lifespan of the material is ca 1120 days. Piper and BHT had predicted lifespans of 
ca 1200 days or greater.  
From a toxicological risk perspective of the degradation products, increasing the time to 
total mass loss (decreasing the rate of degradation) achieves a lower production rate of degradation 
products and a reduced risk, as the overall exposure rate per day is reduced by extending the 
material lifespan by more than 30%.11 For the SMP matrix, toxicity assessments were briefly 
undertaken using a literature review of the degradation products, and it appears the oxalic acid is 
the most concerning degradation product.50-51 In selecting TEA as the alcohol monomer, complete 
particle degradation does not risk the generation of oxalic acid or glyoxal and overall toxicity risk 
from the SMP is reduced. For oxalic acid, 0.54 mg/kg body weight/day (37.8 mg/day for an 
average 70 kg human) is the accepted maximum threshold for no adverse effects.50-51 In the 
presented control SMPs, this corresponds to ca 37 mg total; the use of Piper or BHT to increase 
oxidative stability would, therefore, produce SMPs that generate an average of ca 31 µg oxalic 
acid per day, three orders of magnitude below the threshold for concern. From the 
cytocompatibility analysis, it appears that oxalic acid is the most concerning degradation product. 
In selecting TEA as the alcohol monomer of the particles, complete particle degradation is not 
limited by the generation of oxalic acid or glyoxal.  
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Figure 7. Gravimetric analysis of small molecule containing SMPs (5% wt, A; 10% wt, B) and 
composite SMPs (5% weight, C) in (20% H2O2 with 0.1 M CoCl2 at 37°C). Theoretical 
calculations of gravimetric behavior were performed to compare the real time control lifespan with 
small molecule and microparticle composite SMPs for a 2% H2O2 solution (porcine aneurysm 
conditions) at 37°C (n=7). 
A 
C 
B 
D 
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Figure 8. SEM images of the degradation of composite SMPs compared to control and selected 
small molecule antioxidant-containing SMPs over the course of 7 days in accelerated conditions 
(20% H2O2 with 0.1 M CoCl2 at 37°C) with red dots denoting peroxide, green dots denoting 
antioxidants and blue dots displaying microparticles: (A) day 0, (B) day 3, (C) day 7, with the 
corresponding schematic displaying the erosion of membranes and reduction of strut mass, 
followed by SMP collapse over the same time period (D-F). 5% wt microparticles-containing Piper 
SMP degradation behavior of the SMP composites (D, the equivalent of 2% H2O2 at 37°C). Control 
SMP and Piper SMP at day 0 (G), day 3 (H), and day 7 (I) is presented with the corresponding 
schematic of the same time displaying release of antioxidants accompanying the erosion and 
revealing the microparticles within the SMP matrix. This ultimately allows the foam to retain mass 
and the pore membranes over the initial 3 days in accelerated oxidative solutions. 
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Conclusions 
The use of phenolic and HALS antioxidants was demonstrated for improving oxidative stability 
of SMPs, with only the HALS antioxidant retaining functionality when directly incorporated into 
the SMP. However, phenolic antioxidants could be retained in the SMP matrix when incorporated 
in microparticles. The strain to failure and the elastic moduli were impacted by the inclusion of 
antioxidants directly in the SMP. However, the composite SMPs displayed no statistical variation 
in either property, independent of antioxidant species examined. The retention of the antioxidants 
was examined using in vitro release studies, which ultimately was used to determine that small 
molecule antioxidants are not well retained in the SMP matrix for the examined formulations, but 
through the use of microparticles, retention could be greatly enhanced. This retention was 
demonstrated to be sufficient for increasing the lifespan of the SMP by 25% to 50%, according to 
calculated values, depending on the antioxidant and incorporation method. For the clinical use as 
a biomaterial, the incorporation of antioxidant-containing microparticles to reduce degradation 
was demonstrated to lower the exposure level per day of a degradation product to three orders of 
magnitude below the established limit of concern for oxalic acid, demonstrating the value of this 
method. 
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Species Starting Material (%) at 
conclusion 
Urethane formation (%) Urea formation (%) 
Control (EtOH) 3.7 70.2 26.1 
Piper 45.7 31.7 22.6 
Methyl 32.8 28.0 (19.5)* 19.5 
BHT 100 0 ~100 
Thio 100 0 ~100 
Triphen 100 0 ~100 
 
SI Figure 1. Antioxidant structures used to synthesize oxidatively stable porous SMPs. (A) 
butylated hydroxytoluene, (B) 2,2,6,6 tetramethyl piperidinol, (C) 2,2’-methylenebis(6-tert-
butyl-methylphenol), (D) didodecyl 3,3 thiodipropionate, (E) triphenyl phosphite, and their 
reactions with hexyl isocyanate in model compound studies with quantified urethane and urea 
concentrations determined. * denotes where two urethane linkages were formed as determined 
by LCMS. 
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SI Figure 2. Size distribution of IPDI TEA particles synthesized at varied solvent percentages 
and solution temperatures. 
 
SI Figure 3. SEM images of particles synthesized containing BHT (top) and Piper (bottom). 
 
SI Figure 4. SEM images 
of microparticles made from TEA (left), HPED (middle) and DEA (right). 
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SI Figure 5. SEM images of particles synthesized from IPDI and TEA at 20°C. 
 
 
SI Figure 6. SEM images of particles synthesized from IPDI and TEA 0°C 
 
SI Figure 7. SEM images of particles synthesized from IPDI and TEA at 80°C 
   
SI Figure 8. SEM images of particles synthesized from IPDI and TEA at 65°C 
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SI Figure 9. SEM image of particles synthesized from IPDI and TEA, 60% acetone 
  
SI Figure 10. SEM image of particles synthesized from IPDI and TEA 50% acetone 
  
SI Figure 11. SEM image of particles synthesized from IPDI and TEA 30% acetone 
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SI Figure 12.  Spectroscopic analysis of the antioxidant reactions with isocyanates using model 
compounds BHT, Methyl and Piper (top), and FTIR-ATR of the antioxidant-containing SMPs 
(bottom). 
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SI Figure 13. XPS spectra of example particles comparing the effects of loading during 
synthesis compared with post synthesis of Piper and BHT antioxidants. (C1s (298-280 eV), N1s 
(410-392 eV), O1s (545-525 eV)). 
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SI Figure 14. XPS spectra of Br3p (75-62 eV), Cl2s (210-190 eV), N1s (410-392 eV), O1s (545-
525 eV) for PhB-containing SMPs and particles. 
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SI Figure 15. XPS spectra displaying control SMP formulations, displaying the survey scan (A) 
and specific elemental scans (C1s (298-280 eV, B), N1s (410-392 eV, C), O1s (545-525 eV, D)). 
 
 
 
 
 
 
 
A B 
C D 
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SI Figure 16. SEM image of Nile particle SMP composite of foam pores containing 
microparticles in struts (left), and individual particles (right). 
 
   
SI Figure 17. SEM image of PhB particle SMP composite (top left) and SEM images of 
particles (top center, top right, and bottom). 
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SI Table 1. Mechanical properties of small molecule antioxidant-containing SMPs using HDI 
and 60% TEA/40% HPED alcohol ratio; all samples were tested at room temperature at 5 
mm/min for ASTM Type IV dogbones. 
Foam 
Composition 
Elastic Modulus (MPa) Strain-to-Failure (%) Tensile Strength  
(MPa) 
Toughness (J*m4) 
Control 0.25 ± 0.06 165 ± 21 0.41 ± 0.08 333.1 
Piper 0.28 ± 0.19 167 ± 27 0.61 ± 0.23 786.9 
Methyl 2.32 ± 0.44 104 ± 27 1.77 ± 0.46 1263.8 
BHT 0.24 ± 0.06 176 ± 39 0.97 ± 0.14 940.1 
Thio 0.24 ± 0.06 181 ± 49 0.81 ± 0.21 722.6 
Triphen 0.11 ± 0.02 131 ± 21 0.35 ± 0.06 204.5 
 
 
SI Figure 18. Thermal analysis of antioxidant-containing foams, displaying TGA (top) and DSC 
(below) thermograms. BHT, Piper, Thio, and Methyl seemed to delay thermal oxidation; after 
extractions, Thio still appeared to be in the SMP matrix, as did Methyl, Piper, and BHT (Triphen 
seemed to have been extracted out). 
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SI Figure 19.  GCMS chromatographs for antioxidants extracted from SMPs. 
 
SI Table 2. Mass and concentration of antioxidants added during synthesis and extracted during 
cleaning, determined using GC/MS. 
 Additive Mass 
(g) 
Additive 
Concentration 
(mol) 
Extract Mass 
(g) 
Extract 
Concentration 
(mol) 
Piper 2.000 0.012 0.080 0.000 
Methyl 2.000 0.006 0.155 0.000 
Thio 2.000 0.004 0.149 0.000 
Triphen 2.000 0.007 1.928 0.006 
BHT 2.000 0.009 1.629 0.007 
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SI Figure 20. Accelerated oxidation of TMHDI SMPs containing BHT (left) and predicted 
real time oxidative mass loss of antioxidant (Piper) containing HDI-based SMPs 
(equivalent of 2% H2O2 at 37°C). 
 
 
